CARD11, an essential adaptor protein that activates the nuclear factor (NF)-κB signaling pathway, is reported to be involved in the pathogenesis of RA and could also be a potential therapeutic target [47]. This evidence concerns the gene NFKB1 and rheumatoid arthritis.